Cargando…
Argon-helium knife cryoablation plus programmed cell death protein 1 inhibitor in the treatment of advanced soft tissue sarcomas: there is no evidence of the synergistic effects of this combination therapy
BACKGROUND: Effective treatment for advanced soft tissue sarcomas (STSs) is necessary for improved outcomes. Previous studies have suggested that cryoablation can have a synergistic effect with programmed cell death protein-1 (PD-1) inhibitor in the treatment of malignancy. This study aimed to clari...
Autores principales: | Wang, Jiaqiang, Zong, Dengwei, Dong, Shuping, Gao, Shilei, Yang, Yonghao, Zhang, Peng, Wang, Xin, Yao, Weitao, Tian, Zhichao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509548/ https://www.ncbi.nlm.nih.gov/pubmed/37736543 http://dx.doi.org/10.3389/fonc.2023.1185291 |
Ejemplares similares
-
Efficacy and safety of sintilimab plus doxorubicin in advanced soft tissue sarcoma: A single-arm, phase II trial
por: Tian, Zhichao, et al.
Publicado: (2022) -
Computed tomography-guided argon-helium cryoablation for sacrum chordoma
por: Li, Liang, et al.
Publicado: (2020) -
Argon–Helium Cryoablation for Cutaneous Squamous Cell Carcinoma in the Elderly
por: Huang, Qianwen, et al.
Publicado: (2022) -
Outcomes of ultrasound-guided percutaneous argon-helium cryoablation of hepatocellular carcinoma
por: Yang, Yongping, et al.
Publicado: (2011) -
Nanoparticle albumin-bound paclitaxel and PD-1 inhibitor (sintilimab) combination therapy for soft tissue sarcoma: a retrospective study
por: Tian, Zhichao, et al.
Publicado: (2022)